Female Health Co. (The) (FHCO) Jumps 8.51% on February 04

Equities Staff |

Female Health Co. (The) (FHCO) was among the biggest gainers on the Russell 2000 for Thursday February 04 as the stock popped 8.51% to $1.53, representing a gain of $0.12 per share. Some 242,574 shares traded hands on 569 trades, compared with an average daily volume of 109,648 shares out of a total float of 29.02 million. The stock opened at $1.49 and traded with an intraday range of $1.54 to $1.39.

After today's gains, Female Health Co. (The) reached a market cap of $44.41 million. Female Health Co. (The) has had a trading range between $3.97 and $1.16 over the last year, and it had a 50-day SMA of $1.40 and a 200-day SMA of $1.79.

The stock has a P/E Ratio of 8.6.

Female Health Co is engaged in marketing, manufacturing and distribution of a consumer health care product, the FC2 female condom. Its products provide dual protection against unintended pregnancy and sexually transmitted infections, including HIV/AIDS.

Female Health Co. (The) is based out of Chicago, IL and has some 180 employees. Its CEO is O.B. Parrish.

For a complete fundamental analysis analysis of Female Health Co. (The), check out Equities.com’s Stock Valuation Analysis report for FHCO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…